Sign Up for Keystone Heart Updates
The Risk of Brain Injury During TAVR & the Role of TriGUARD 3™ CEP Device in Reducing the Probability of Brain Injury During the Procedure The transcatheter aortic valve replacement (TAVR) has become an established and widely adopted treatment for patients who are under the risk...
Keystone Heart is pleased to share the results from REFLECT Phase II: A Randomized Trial of a Cerebral Embolic Protection Device During Transcatheter Aortic Valve Replacement (TAVR) have been accepted for presentation in a late-breaking clinical science session at the upcoming Cardiovascular Research Foundation TCT...
US
EU